Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

149.85 +0.90 (+0.60%)
Official Closing Price Updated: 4:10 PM EDT, May 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,513,288
Open 148.98
Bid (Size) 149.85 (8)
Ask (Size) 149.90 (1)
Prev. Close 148.95
Today's Range 148.89 - 150.10
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.18%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:ZLAB),(NASDAQ:NTBL),(NASDAQ:CRDF),(NYSE:JNJ) EQNX::TICKER_END 
Via FinancialNewsMedia
Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
Via InvestorPlace

Performance

YTD
-6.33%
-6.33%
1 Month
-1.15%
-1.15%
3 Month
-5.15%
-5.15%
6 Month
-0.33%
-0.33%
1 Year
-6.95%
-6.95%

More News

Read More
What Is the Dividend Payout for Johnson & Johnson Stock?
Via The Motley Fool
Comparing Johnson & Johnson With Industry Competitors In Pharmaceuticals Industry
Via Benzinga
The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024
Via InvestorPlace
Topics Stocks
Exposures US Equities
Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024
Via InvestorPlace
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy
Via Benzinga
Shockwave Medical Reports First Quarter 2024 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
3 Biotech Stocks to Double Your Money in the Next 24 Months
Via InvestorPlace
Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data
Via Benzinga
Steady Dividend Plays: 3 Aristocrat Stocks to Own Now
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical,
From Brodsky & Smith LLC
Via GlobeNewswire
Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?
Via InvestorPlace
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Via MarketBeat
Exposures COVID-19
Johnson & Johnson: A Healthcare Giant That's Looking More Attractive By The Day
Via Talk Markets
Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
Via Investor's Business Daily
3 Dividend Growth Stocks that Just Raised Their Payouts
Via The Motley Fool
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge
Via InvestorPlace
Nasdaq, S&P 500 Futures Rise Ahead Of Apple Earnings: Why This Analyst Thinks 'No Cut' Scenario May Not Be Negative For Market
Via Benzinga
Topics Stocks
Exposures US Equities
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: DecisionPoint Systems, Inc. (NYSE American - DPSI), AdTheorent Holding Company, Inc. (Nasdaq – ADTH), Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical,
From Brodsky & Smith LLC
Via GlobeNewswire
Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.